Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study

D. Bliuc; T. Tran; T. van Geel; J. D. Adachi; C. Berger; J. van den Bergh; J. A. Eisman; P. Geusens; D. Goltzman; D. A. Hanley; R. G. Josse; S. Kaiser; C. S. Kovacs; L. Langsetmo; J. C. Prior; T. Nguyen; J. R. Center; CaMOS Res Grp

doi:10.1007/s00198-018-4806-0

Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study

D. Bliuc^*, T. Tran, T. van Geel, J. D. Adachi, C. Berger, J. van den Bergh, J. A. Eisman, P. Geusens, D. Goltzman, D. A. Hanley, R. G. Josse, S. Kaiser, C. S. Kovacs, L. Langsetmo, J. C. Prior, T. Nguyen, J. R. Center, CaMOS Res Grp

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	817-828
Number of pages	12
Journal	Osteoporosis International
Volume	30
Issue number	4
DOIs	https://doi.org/10.1007/s00198-018-4806-0
Publication status	Published - Apr 2019

Keywords

Bisphosphonate
Fracture
Mortality risk
Osteoporosis
Prospective study
DELTA T-CELLS
SUBSEQUENT FRACTURE
BONE LOSS
OSTEOPOROTIC FRACTURE
ZOLEDRONIC ACID
HIP FRACTURE
WOMEN
MEN
PAMIDRONATE
EFFICACY

Access to Document

10.1007/s00198-018-4806-0

Cite this

Bliuc, D., Tran, T., van Geel, T., Adachi, J. D., Berger, C., van den Bergh, J., Eisman, J. A., Geusens, P., Goltzman, D., Hanley, D. A., Josse, R. G., Kaiser, S., Kovacs, C. S., Langsetmo, L., Prior, J. C., Nguyen, T., Center, J. R., & CaMOS Res Grp (2019). Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study. Osteoporosis International, 30(4), 817-828. https://doi.org/10.1007/s00198-018-4806-0

Bliuc, D. ; Tran, T. ; van Geel, T. ; Adachi, J. D. ; Berger, C. ; van den Bergh, J. ; Eisman, J. A. ; Geusens, P. ; Goltzman, D. ; Hanley, D. A. ; Josse, R. G. ; Kaiser, S. ; Kovacs, C. S. ; Langsetmo, L. ; Prior, J. C. ; Nguyen, T. ; Center, J. R. ; CaMOS Res Grp. / Mortality risk reduction differs according to bisphosphonate class : a 15-year observational study. In: Osteoporosis International. 2019 ; Vol. 30, No. 4. pp. 817-828.

@article{f4b18ff3fa6946ed8b2382261a87d8c1,

title = "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study",

keywords = "Bisphosphonate, Fracture, Mortality risk, Osteoporosis, Prospective study, DELTA T-CELLS, SUBSEQUENT FRACTURE, BONE LOSS, OSTEOPOROTIC FRACTURE, ZOLEDRONIC ACID, HIP FRACTURE, WOMEN, MEN, PAMIDRONATE, EFFICACY",

author = "D. Bliuc and T. Tran and {van Geel}, T. and Adachi, {J. D.} and C. Berger and {van den Bergh}, J. and Eisman, {J. A.} and P. Geusens and D. Goltzman and Hanley, {D. A.} and Josse, {R. G.} and S. Kaiser and Kovacs, {C. S.} and L. Langsetmo and Prior, {J. C.} and T. Nguyen and Center, {J. R.} and {CaMOS Res Grp}",

year = "2019",

month = apr,

doi = "10.1007/s00198-018-4806-0",

language = "English",

volume = "30",

pages = "817--828",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer-Verlag London Ltd.",

number = "4",

}

Bliuc, D, Tran, T, van Geel, T, Adachi, JD, Berger, C, van den Bergh, J, Eisman, JA, Geusens, P, Goltzman, D, Hanley, DA, Josse, RG, Kaiser, S, Kovacs, CS, Langsetmo, L, Prior, JC, Nguyen, T, Center, JR & CaMOS Res Grp 2019, 'Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study', Osteoporosis International, vol. 30, no. 4, pp. 817-828. https://doi.org/10.1007/s00198-018-4806-0

Mortality risk reduction differs according to bisphosphonate class : a 15-year observational study. / Bliuc, D.; Tran, T.; van Geel, T.; Adachi, J. D.; Berger, C.; van den Bergh, J.; Eisman, J. A.; Geusens, P.; Goltzman, D.; Hanley, D. A.; Josse, R. G.; Kaiser, S.; Kovacs, C. S.; Langsetmo, L.; Prior, J. C.; Nguyen, T.; Center, J. R.; CaMOS Res Grp.

In: Osteoporosis International, Vol. 30, No. 4, 04.2019, p. 817-828.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Mortality risk reduction differs according to bisphosphonate class

T2 - a 15-year observational study

AU - Bliuc, D.

AU - Tran, T.

AU - van Geel, T.

AU - Adachi, J. D.

AU - Berger, C.

AU - van den Bergh, J.

AU - Eisman, J. A.

AU - Geusens, P.

AU - Goltzman, D.

AU - Hanley, D. A.

AU - Josse, R. G.

AU - Kaiser, S.

AU - Kovacs, C. S.

AU - Langsetmo, L.

AU - Prior, J. C.

AU - Nguyen, T.

AU - Center, J. R.

AU - CaMOS Res Grp

PY - 2019/4

Y1 - 2019/4

KW - Bisphosphonate

KW - Fracture

KW - Mortality risk

KW - Osteoporosis

KW - Prospective study

KW - DELTA T-CELLS

KW - SUBSEQUENT FRACTURE

KW - BONE LOSS

KW - OSTEOPOROTIC FRACTURE

KW - ZOLEDRONIC ACID

KW - HIP FRACTURE

KW - WOMEN

KW - MEN

KW - PAMIDRONATE

KW - EFFICACY

U2 - 10.1007/s00198-018-4806-0

DO - 10.1007/s00198-018-4806-0

M3 - Article

C2 - 30607457

VL - 30

SP - 817

EP - 828

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 4

ER -